This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

Unique collaboration opportunities for UK SMEs working on drug discovery

22 November 2017

Are you a UK SME working in drug discovery?
Do you need drug-target interaction data including for large or complex drug targets?
Identify dynamic and conformational changes in the target?
Have you reached the limits of your structure guided approach?
Do you want to explore high resolution polymorph, metabolite, or pro-drug structural analysis?


The Medicines Discovery Catapult are inviting UK SMEs working in drug discovery and drug re-purposing to collaborate on high-resolution analysis.

On offer is access to an atomic resolution Solid State NMR (SSNMR) at our new facility within the University of Warwick, along with world-leading scientific support, including data analysis and interpretation.

If you are a UK-registered micro, small or medium-sized enterprise engaged in drug discovery and drug re-purposing we are inviting you to apply to collaborate by Thursday 30 November 2017.

“We’re looking for innovative, dynamic partners with technically feasible proposals that will bring about significant new advances. This is an excellent opportunity for a UK SME to accelerate their R&D.” – Dr Peter Simpson, Chief Scientific Officer of Medicines Discovery Catapult.

Anyone interested in applying can find out more details HERE. The Expression of Interest form can be accessed HERE which should be returned to info@md.catapult.org.uk by Thursday 30 November.

MD Catapult